quinoxalines has been researched along with Autism in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jackson, MC; Jensen, FE; Joseph, A; Klein, PM; Lippman-Bell, JJ; Obeid, M; Rakhade, SN | 1 |
| Aman, M; Anand, R; Arnold, LE | 1 |
2 other study(ies) available for quinoxalines and Autism
| Article | Year |
|---|---|
AMPA receptor antagonist NBQX attenuates later-life epileptic seizures and autistic-like social deficits following neonatal seizures.
Topics: Aging; Animals; Animals, Newborn; Autistic Disorder; Behavior, Animal; Disease Models, Animal; Hippocampus; Male; Neurons; Quinoxalines; Rats; Rats, Long-Evans; Receptors, AMPA; Seizures | 2013 |
Varenicline in autistic disorder: hypothesis and case report of single-patient crossover.
Topics: Autistic Disorder; Benzazepines; Child; Cross-Over Studies; Humans; Male; Nicotinic Agonists; Quinoxalines; Varenicline | 2013 |